Actinogen Medical Limited (ASX:ACW)
0.0340
+0.0010 (3.03%)
Mar 31, 2026, 3:51 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 122.11 million as of March 31, 2026. Its market cap has increased by 29.93% in one year.
Market Cap
122.11M
Enterprise Value
115.80M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 122.11M, an increase of 841.32%. That is a compound annual growth rate of 12.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 118.52M | -39.03% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 193.26M |
| Dimerix | 177.12M |
| Recce Pharmaceuticals | 133.02M |
| Amplia Therapeutics | 123.14M |
| Paradigm Biopharmaceuticals | 115.68M |
| Island Pharmaceuticals | 109.37M |
| Alterity Therapeutics | 97.88M |
| Botanix Pharmaceuticals | 93.16M |